These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 25231363

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L.
    Int J Clin Pract; 2014 Jan; 68(1):60-82. PubMed ID: 24165478
    [Abstract] [Full Text] [Related]

  • 8. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L.
    Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762
    [Abstract] [Full Text] [Related]

  • 9. Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.
    Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-Wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D.
    J Clin Sleep Med; 2016 Sep 15; 12(9):1215-25. PubMed ID: 27397664
    [Abstract] [Full Text] [Related]

  • 10. Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.
    Owen RT.
    Drugs Today (Barc); 2016 Jan 15; 52(1):29-40. PubMed ID: 26937493
    [Abstract] [Full Text] [Related]

  • 11. Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.
    Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-Wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D.
    Psychopharmacology (Berl); 2017 Jun 15; 234(11):1703-1711. PubMed ID: 28265715
    [Abstract] [Full Text] [Related]

  • 12. Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L.
    Int J Clin Pract; 2013 Nov 15; 67(11):1089-104. PubMed ID: 24016209
    [Abstract] [Full Text] [Related]

  • 13. Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L.
    Int J Clin Pract; 2017 Jul 15; 71(7):. PubMed ID: 28497864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.
    Herring WJ, Connor KM, Ivgy-May N, Snyder E, Liu K, Snavely DB, Krystal AD, Walsh JK, Benca RM, Rosenberg R, Sangal RB, Budd K, Hutzelmann J, Leibensperger H, Froman S, Lines C, Roth T, Michelson D.
    Biol Psychiatry; 2016 Jan 15; 79(2):136-48. PubMed ID: 25526970
    [Abstract] [Full Text] [Related]

  • 17. Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    Kishi T, Matsunaga S, Iwata N.
    PLoS One; 2015 Jan 15; 10(8):e0136910. PubMed ID: 26317363
    [Abstract] [Full Text] [Related]

  • 18. Suvorexant: something new for sleep?
    Reddy A, Puvvada SC, Kommisetti S, El-Mallakh RS, Lippmann S.
    Acta Neuropsychiatr; 2015 Feb 15; 27(1):53-5. PubMed ID: 25397996
    [Abstract] [Full Text] [Related]

  • 19. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L.
    Int J Clin Pract; 2011 Feb 15; 65(2):189-210. PubMed ID: 21129135
    [Abstract] [Full Text] [Related]

  • 20. Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data.
    Snyder E, Ma J, Svetnik V, Connor KM, Lines C, Michelson D, Herring WJ.
    Sleep Med; 2016 Mar 15; 19():93-100. PubMed ID: 27198953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.